Skip to main content

Find Clinical Trials

Clinical trial condition

HNSCC

Explore clinical trials studying HNSCC. Study availability and eligibility vary by location and protocol.

72 public trials 36 recruiting studies

Refine in advanced search Browse all conditions

HNSCC trial results

Recruiting

Proton Versus Photon Therapy in Head and Neck Squamous Cell Carcinomas.

NCT07580300

Conditions: Carcinoma, Carcinoma, Squamous Cell, HNSCC, +6 more
Locations: Haukeland University Hospital Bergen, Norway

Oslo University Hospital, Radiumhospitalet Oslo, Norway

University Hospital of Northern Norway Tromsø, Norway

St. Olavs Hospital Trondheim, Norway

View Trial Details

Recruiting

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

NCT07085091

Conditions: Bronchial Neoplasms, CRC (Colorectal Cancer), Carcinoma, +38 more
Locations: ALX Center 7 Tampa, Florida, United States

ALX Center 8 Farmington Hills, Michigan, United States

ALX Center 3 Grand Rapids, Michigan, United States

ALX Center 6 Portland, Oregon, United States

View Trial Details

Recruiting

High-Resolution PET-CT Imaging for Surgical Margin Visualization

NCT06915454

Conditions: Cancer, Carcinoma, Carcinoma, Squamous Cell, +19 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Recruiting

Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC

NCT07040072

Conditions: Carcinoma, Carcinoma, Squamous Cell, HNSCC, +6 more
Locations: Beijing Tongren Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors

NCT06190275

Conditions: Carcinoma, Carcinoma, Squamous Cell, HNSCC, +6 more
Locations: Shanghai Ninth People's Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors

NCT07035249

Conditions: Carcinoma, Carcinoma, Squamous Cell, DCSZ11, +8 more
Locations: Sichuan University West China Hospital, Chengdu, Sichuan Chengdu, Sichuan, China

View Trial Details

Recruiting

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

NCT06305962

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +46 more
Locations: Nepean Hospital Kingswood, New South Wales, Australia

Wollongong Hospital Wollongong, New South Wales, Australia

Gold Coast University Hospital Southport, Queensland, Australia

Cancer Research SA (CRSA) Adelaide, South Australia, Australia

View Trial Details

Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

NCT07182149

Conditions: Adenocarcinoma Of Esophagus, Adnexal Diseases, Breast Diseases, +39 more
Locations: Normunity Investigational Site Denver, Colorado, United States

Normunity Investigational Site New Haven, Connecticut, United States

Normunity Investigational Site Minneapolis, Minnesota, United States

Normunity Investigational Site Maumee, Ohio, United States

View Trial Details

Recruiting

Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer

NCT06736379

Conditions: Carcinoma, Carcinoma, Squamous Cell, HNSCC, +22 more
Locations: Stanford University Stanford, California, United States

View Trial Details

Recruiting

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

NCT05859074

Conditions: Adenocarcinoma, Adenocarcinoma, Sebaceous, Adnexal Carcinoma, +58 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States

View Trial Details